Please use this identifier to cite or link to this item:
https://idr.nitk.ac.in/jspui/handle/123456789/16284
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hadagali G.S. | - |
dc.contributor.author | Shettar, Iranna. M | - |
dc.contributor.author | Mulimani R. | - |
dc.contributor.author | Kadakol M. | - |
dc.date.accessioned | 2021-05-05T10:30:06Z | - |
dc.date.available | 2021-05-05T10:30:06Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | International Journal of Pharmaceutical Research Vol. 12 , 2 , p. 536 - 543 | en_US |
dc.identifier.uri | https://doi.org/10.31838/ijpr/2020.12.02.0061 | - |
dc.identifier.uri | http://idr.nitk.ac.in/jspui/handle/123456789/16284 | - |
dc.description.abstract | The study presents the pharmacology research output with particular reference to the top ten Asian countries for the period of thirty years (1988 – 2017) using various Scientometric indicators. The data for the study were retrieved from the Web of Sciencedatabase for the period between 1988 and 2017. The outcomes of the study reveal that with 3.24 Compound Annual Growth Rate (CAGR), the global pharmacology research output is growing so fast. Japan, China and India were leading Asian countries with nearly 20% of Pharmacology research publications together. Top 10 productive Asian counties have shown an increase in their global publication share, exceptJapan. Iran and China showed positive shift in TAI in research activity during the study. The Chinese Academy of Sciences (9,539) was the highly productive institution from Asia. The collaboration trend is towards multi and mega authorship instead of solo research. © 2020, Advanced Scientific Research. All rights reserved. | en_US |
dc.title | Global pharmacy and pharmacology research: A scientometric study (1988 – 2017) | en_US |
dc.type | Article | en_US |
Appears in Collections: | 1. Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.